Ureteric Stenting Versus Non-stenting Following Uncomplicated Ureteroscopic Lithotripsy

Ureter Stone Clinical Trial

Official title:

Ureteric Stenting Versus Non-stenting Following Uncomplicated Ureteroscopic Lithotripsy: A Prospective Randomized Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04145063
• Other study ID #: Sad2019
• Status: Completed
• Phase: N/A
• Start date: February 2, 2016
• Est. completion date: December 1, 2020

Study information

• Verified date: August 2021
• Source: University of Jordan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to compare three groups of patients who underwent uncomplicated ureteroscopic lithotripsy (URSL) to evaluate whether stents could be eliminated after the procedure

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: December 1, 2020
• Est. primary completion date: June 1, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Age 18 years or older

• unilateral ureteric stones managed by ureteroscopy

Exclusion Criteria:

• Stone size < 2 cm

• bilateral ureteral stones

• incomplete stone removal due to impacted stones

• failed ureteroscopic access to the stone

• stone migration to the kidney

• pregnancy

• active urinary tract infection

• solitary kidney

• ureteral stent placed preoperatively

• severe mucosal injury or perforation

• suspected additional ureteral pathology such as ureteral stricture

• urothelial carcinoma or polyp.

Related Conditions & MeSH terms

• Ureter Stone
• Ureteral Calculi
• Ureterolithiasis

Intervention

Other:
• no stent
following uretroscopy, no stent will be placed

Locations

Country	Name	City	State
Jordan	Jordan University Hospital	Amman

Sponsors (1)

Lead Sponsor	Collaborator
University of Jordan

Country where clinical trial is conducted

Jordan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Analog Score (VAS)	Visual Analog Score (VAS) for flank pain and dysuria score, urgency, frequency, suprapubic pain, hematuria, analgesia requirement, operative time, re-hospitalization, and return to normal physical activity. This is a widely-used scale. It a unidimensional measure of pain intensity. It is administered as a straight horizontal line orientated from the left (worst) to the right (best) , where the patient indicates their situation.	1 week